> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# BrightSpring Reiterates 2027 Profit Growth Goal And Says It Could Do '400 Of EBITDA' In Deals
- URL: https://www.bullished.co/brightspring-reiterates-2027-profit-growth-goal-and-says-it-could-do-400-of-ebitda-in-ba53ea1b/
- Published: 2026-10-30T14:02:16.000Z
- Updated: 2026-10-30T14:02:16.000Z
- Description: The home-health and pharmacy company still expects at least 15% to 20% organic adjusted EBITDA growth in 2027, now off a larger 2026 base.
- Author: Matteo Parrino
- Tags: Earnings, BTSG, Industry: Healthcare

[BrightSpring Health Services](https://www.bullished.co/tag/btsg/) still expects at least 15% to 20% organic adjusted EBITDA growth in 2027, CEO Jon Rousseau said on the company's third-quarter earnings call Friday, and the company is leaning toward somewhat larger acquisitions. BrightSpring, which provides pharmacy and in-person home and community care to medically complex patients, reported [$228 million of adjusted EBITDA](https://www.globenewswire.com/news-release/2026/10/30/3392093/0/en/brightspring-health-services-inc-reports-third-quarter-2026-financial-results-and-increases-full-year-2026-guidance.html?ref=bullished.co) for the quarter, up 42% from a year earlier.

## A bigger base for 2027 growth

Rousseau said the company reiterates the 15% to 20% target from its analyst day, "however, now off of a significantly larger EBITDA base in 2026." He expects similar year-over-year growth rates in each quarter of next year.

CFO Jen Phipps added that second-half 2027 growth should run a little higher than the first half, in line with normal seasonal patterns. She said 2026 adjusted EBITDA is now expected at $850 million to $860 million, which is 37.6% to 39.3% growth over 2025\. Full 2027 guidance is due when the company reports fourth-quarter results in February.

A Mizuho analyst asked whether that even cadence means limited-distribution drugs, rather than generics, drive growth. Rousseau said the company would stick to its prepared remarks and pointed to a "plethora of growth drivers" across service lines.

## Deal appetite grows with the balance sheet

Asked by a UBS analyst about acquisitions, now that leverage sits below the company's 2.5 times target, Rousseau said BrightSpring has leaned toward slightly larger deals than small tuck-ins, though still around "20-ish of EBITDA or below." He said: "we could do 400 of EBITDA and M&A tomorrow if we wanted to," adding he was not saying it "tongue-in-cheek" and that the company is "extremely intentional" in diligence.

Rousseau said BrightSpring has not entertained deals in partnership with anyone else and does not expect to. Leverage ended September at [1.79 times](https://www.globenewswire.com/news-release/2026/10/30/3392093/0/en/brightspring-health-services-inc-reports-third-quarter-2026-financial-results-and-increases-full-year-2026-guidance.html?ref=bullished.co), down from 2.15 times at the end of June, and Phipps said the company is evaluating its capital structure heading into 2027 to support growth plans.

## The quarter behind the outlook

Revenue rose 26% to $4.2 billion, with adjusted earnings of $0.54 per share. Pharmacy Solutions revenue was $3.7 billion, while Provider Services revenue of $481 million grew 31%. Specialty and infusion scripts grew 29%.

Operating cash flow was $204 million in the quarter, and management projects at least $700 million for the year, excluding the community living sale. BrightSpring shares were up 12.54% at $67.77 in Friday morning trading.

Management will lay out full 2027 guidance when it reports fourth-quarter results in February.

Learn

- [How To Read An Earnings Call Transcript: Start With Guidance, Then Find What's Missing →](https://www.bullished.co/learn/how-to-read-an-earnings-call/)  
How to read an earnings call transcript: check guidance first, look for dropped metrics, compare growth with last quarter, and watch hedged wording.

### Sources

- [BTSG Ahead of Q3 Earnings: Can Growth Offset Ongoing IRA Risks?](https://finance.yahoo.com/healthcare/articles/btsg-ahead-q3-earnings-growth-144300994.html?.tsrc=rss&ref=bullished.co) — Yahoo Finance
- [BrightSpring Health Services Non-GAAP EPS of $0.54 beats by $0.07, revenue of $4.21B beats by $](https://seekingalpha.com/news/4661242-brightspring-health-services-non-gaap-eps-of-054-beats-by-007-revenue-of-421b-beats-by-340m-raises-fy-guidance?ref=bullished.co) — seekingalpha.com
- [BrightSpring Health Services Q3 2026 Earnings Preview (NASDAQ:BTSG) | Seeking Alpha](https://seekingalpha.com/news/4660530-brightspring-health-services-q3-2026-earnings-preview?ref=bullished.co) — seekingalpha.com
- [BrightSpring Health Services : Articles :: Law360](https://www.law360.com/companies/brightspring-health-services?article%5Frelated%5Fcontent=1&ref=bullished.co) — law360.com
- [BrightSpring Health Services, Inc. Reports Third Quarter](https://www.globenewswire.com/news-release/2026/10/30/3392093/0/en/brightspring-health-services-inc-reports-third-quarter-2026-financial-results-and-increases-full-year-2026-guidance.html?ref=bullished.co) — globenewswire.com

### More on BrightSpring Health Services

- [BrightSpring Stock Soars 12%, Adding $1.4 Billion, As Company Raises 2026 Revenue Forecast](https://www.bullished.co/brightspring-stock-soars-12-adding-1-4-billion-as-company-raises-2026-revenue-forecast-4959bcda/)
- [BrightSpring Lifts 2026 Outlook As Quarterly Revenue Climbs 26.4% To $4.2 Billion](https://www.bullished.co/brightspring-lifts-2026-outlook-as-quarterly-revenue-climbs-26-4-to-4-2-billion-8e827686/)

[All BrightSpring Health Services (BTSG) coverage →](https://www.bullished.co/tag/btsg/)